University of California–San Francisco researcher Cristin Kearns dropped a promising career at the Kaiser Foundation to dig through sugar industry archives for a smoking gun. With help from the man who brought down Big Tobacco, she’s now proving that Big Sugar steered scientists away from looking at the ingredient’s harmful effects.
The morality of human embryonic stem cell research has long been contentious, but new discoveries could end the controversy.
Type 1 diabetes management is hard work, and any misstep could spell disaster. New advances in Big Data could ease the burden.
Inside the promising marriage between data and health care: How health quantification could alleviate Parkinson's symptoms and improve the lives of Type 1 diabetics.
It's becoming easier to track health data for our own casual use. But for some people—like Ph.D student Maria Qadri, a Type 1 diabetic—it could have a huge impact on quality of life.
New data shows that the incidence of Type 1 and Type 2 diabetes is growing among young Americans. But the rise of Type 1 remains mostly a mystery.
In an experiment, scientists found a correlation between low blood glucose and higher levels of spousal frustration.
The single participant in a groundbreaking—and controversial—study is forcing clinicians to confront the thorny ethical issues surrounding the sequencing of individual genomes to offer a glimpse at what the future of medicine may look like.
Advocates look to expand programs that address a legacy of the Pol Pot era: an epidemic of heart disease, diabetes and stroke among Cambodian-Americans.